Furthermore, other pre-clinical studies have demonstrated that the inhibition of autophagy can overcome the emergence of resistance to tyrosine kinase inhibitors in NSCLC and ALK-positive lung cancer (84, 85). This evidence concerns the gene ALK and lung carcinoma.